The paradoxical increase in FGF21 levels in obesity and diabetes has been reported in many studies (10, 19, 20), leading to the hypothesis of a potential FGF21-resistant state (21). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.